Atrial fibrillation is associated with an increased risk of stroke, heart failure and all-cause mortality. Formerly, guidelines recommended only opportunistic screening for atrial fibrillation in patients aged ≥65 years. Now, more aggressive screening and treatment of atrial fibrillation is being considered.